Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1

Giorgio Zauli, Marco Vitale, Davide Gibellini, Silvano Capitani

Research output: Contribution to journalArticle

Abstract

Human CD34+ hematopoietic progenitor cells, stringently purified from the peripheral blood of 20 normal donors, showed an impaired survival and clonogenic capacity after exposure to either heat-inactivated human immunodeficiency virus (HIV) 1 (strain IIIB) or cross-linked envelope gp120. Cell cycle analysis, performed at different times in serum-free liquid culture, showed an accumulation in G0/G1 in HIV-1- or gp120-treated cells and a progressive increase of cells with subdiploid DNA content, characteristic of apoptosis. In blocking experiments with anti-transforming growth factor (TGF) β1 neutralizing serum or TGF-β1 oligonucleotides, we demonstrated that the HIV-1- or gp120-mediated suppression of CD34+ cell growth was almost entirely due to an upregulation of endogenous TGF-β1 produced by purified hematopoietic progenitors. Moreover, by using a sensitive assay on the CCL64 cell line, increased levels of bioactive TGF-β1 were recovered in the culture supernatant of HIV-1/gp120-treated CD34+ cells. Anti-TGF-β1 neutralizing serum or TGF-β1 oligonucleotides were also effective in inducing a significant increase of the plating efficiency of CD34+ cells, purified from the peripheral blood of three HIV-1-seropositive individuals, suggesting that a similar mechanism may be also operative in vivo. The relevance of these findings to a better understanding of the pathogenesis of HIV-1-related cytopenias is discussed.

Original languageEnglish
Pages (from-to)99-108
Number of pages10
JournalJournal of Experimental Medicine
Volume183
Issue number1
DOIs
Publication statusPublished - Jan 1 1996

Fingerprint

Transforming Growth Factors
Hematopoietic Stem Cells
HIV-1
Oligonucleotides
Serum
Cell Cycle
Up-Regulation
Hot Temperature
Apoptosis
Cell Line
Survival
DNA
Growth

ASJC Scopus subject areas

  • Immunology

Cite this

Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1. / Zauli, Giorgio; Vitale, Marco; Gibellini, Davide; Capitani, Silvano.

In: Journal of Experimental Medicine, Vol. 183, No. 1, 01.01.1996, p. 99-108.

Research output: Contribution to journalArticle

@article{ec0e337bd6c34c7f9e47f14f20d8c64b,
title = "Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1",
abstract = "Human CD34+ hematopoietic progenitor cells, stringently purified from the peripheral blood of 20 normal donors, showed an impaired survival and clonogenic capacity after exposure to either heat-inactivated human immunodeficiency virus (HIV) 1 (strain IIIB) or cross-linked envelope gp120. Cell cycle analysis, performed at different times in serum-free liquid culture, showed an accumulation in G0/G1 in HIV-1- or gp120-treated cells and a progressive increase of cells with subdiploid DNA content, characteristic of apoptosis. In blocking experiments with anti-transforming growth factor (TGF) β1 neutralizing serum or TGF-β1 oligonucleotides, we demonstrated that the HIV-1- or gp120-mediated suppression of CD34+ cell growth was almost entirely due to an upregulation of endogenous TGF-β1 produced by purified hematopoietic progenitors. Moreover, by using a sensitive assay on the CCL64 cell line, increased levels of bioactive TGF-β1 were recovered in the culture supernatant of HIV-1/gp120-treated CD34+ cells. Anti-TGF-β1 neutralizing serum or TGF-β1 oligonucleotides were also effective in inducing a significant increase of the plating efficiency of CD34+ cells, purified from the peripheral blood of three HIV-1-seropositive individuals, suggesting that a similar mechanism may be also operative in vivo. The relevance of these findings to a better understanding of the pathogenesis of HIV-1-related cytopenias is discussed.",
author = "Giorgio Zauli and Marco Vitale and Davide Gibellini and Silvano Capitani",
year = "1996",
month = "1",
day = "1",
doi = "10.1084/jem.183.1.99",
language = "English",
volume = "183",
pages = "99--108",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "1",

}

TY - JOUR

T1 - Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor β1

AU - Zauli, Giorgio

AU - Vitale, Marco

AU - Gibellini, Davide

AU - Capitani, Silvano

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Human CD34+ hematopoietic progenitor cells, stringently purified from the peripheral blood of 20 normal donors, showed an impaired survival and clonogenic capacity after exposure to either heat-inactivated human immunodeficiency virus (HIV) 1 (strain IIIB) or cross-linked envelope gp120. Cell cycle analysis, performed at different times in serum-free liquid culture, showed an accumulation in G0/G1 in HIV-1- or gp120-treated cells and a progressive increase of cells with subdiploid DNA content, characteristic of apoptosis. In blocking experiments with anti-transforming growth factor (TGF) β1 neutralizing serum or TGF-β1 oligonucleotides, we demonstrated that the HIV-1- or gp120-mediated suppression of CD34+ cell growth was almost entirely due to an upregulation of endogenous TGF-β1 produced by purified hematopoietic progenitors. Moreover, by using a sensitive assay on the CCL64 cell line, increased levels of bioactive TGF-β1 were recovered in the culture supernatant of HIV-1/gp120-treated CD34+ cells. Anti-TGF-β1 neutralizing serum or TGF-β1 oligonucleotides were also effective in inducing a significant increase of the plating efficiency of CD34+ cells, purified from the peripheral blood of three HIV-1-seropositive individuals, suggesting that a similar mechanism may be also operative in vivo. The relevance of these findings to a better understanding of the pathogenesis of HIV-1-related cytopenias is discussed.

AB - Human CD34+ hematopoietic progenitor cells, stringently purified from the peripheral blood of 20 normal donors, showed an impaired survival and clonogenic capacity after exposure to either heat-inactivated human immunodeficiency virus (HIV) 1 (strain IIIB) or cross-linked envelope gp120. Cell cycle analysis, performed at different times in serum-free liquid culture, showed an accumulation in G0/G1 in HIV-1- or gp120-treated cells and a progressive increase of cells with subdiploid DNA content, characteristic of apoptosis. In blocking experiments with anti-transforming growth factor (TGF) β1 neutralizing serum or TGF-β1 oligonucleotides, we demonstrated that the HIV-1- or gp120-mediated suppression of CD34+ cell growth was almost entirely due to an upregulation of endogenous TGF-β1 produced by purified hematopoietic progenitors. Moreover, by using a sensitive assay on the CCL64 cell line, increased levels of bioactive TGF-β1 were recovered in the culture supernatant of HIV-1/gp120-treated CD34+ cells. Anti-TGF-β1 neutralizing serum or TGF-β1 oligonucleotides were also effective in inducing a significant increase of the plating efficiency of CD34+ cells, purified from the peripheral blood of three HIV-1-seropositive individuals, suggesting that a similar mechanism may be also operative in vivo. The relevance of these findings to a better understanding of the pathogenesis of HIV-1-related cytopenias is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0030071481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030071481&partnerID=8YFLogxK

U2 - 10.1084/jem.183.1.99

DO - 10.1084/jem.183.1.99

M3 - Article

C2 - 8551249

AN - SCOPUS:0030071481

VL - 183

SP - 99

EP - 108

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 1

ER -